PSA's February 2026 Price Hike Details PSA implemented these psa grading price increases in February 2026 to match surging ...
A quick guide to what's safe, what's risky, and what's gross.
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results ...
The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...
4don MSN
Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...
The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...
A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results